PAK1 and neoplasm: The study of PAK1 in a PDAC mouse model demonstrate that the inhibition of PAK1 increases the tumor infiltration of CD4+ and CD8+ T cells, while reducing the intrinsic and PSC-induced PD-L1 expression in PDAC cells, which were then sensitized to cytotoxic lymphocytes [56].